Paul Baas

发表

What does photodynamic therapy have to offer radiation oncologists (or their cancer patients)?

P Baas, F. Stewart, W. Star, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Enhancement of photodynamic therapy by mitomycin C: a preclinical and clinical study.

H. Oppelaar, F. Stewart, P. Baas, 1996, British Journal of Cancer.

Interaction of the bioreductive drug SR 4233 and photodynamic therapy using photofrin in a mouse tumor model.

H. Oppelaar, F. Stewart, P. Baas, 1993, International journal of radiation oncology, biology, physics.

A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: a combined analysis of 10 EORTC trials.

J. V. van Meerbeeck, R. Sylvester, P. Baas, 2009, European journal of cancer.

Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma.

A. Hart, P. Baas, H. Schouwink, 1999, Lung cancer.

Cytoreductive Surgery Combined With Intraoperative Hyperthermic Intrathoracic Chemotherapy for Stage I Malignant Pleural Mesothelioma

F. Zoetmulder, V. Verwaal, S. Ruth, 2003, Annals of Surgical Oncology.

The activity of raltitrexed (Tomudex) in malignant pleural mesothelioma: an EORTC phase II study (08992).

G. Giaccone, M. J. van de Vijver, K. Nackaerts, 2003, European journal of cancer.

EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer.

P. Nederlof, P. Baas, D. de Jong, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma: A follow-up study.

L. Boersma, J. Lebesque, S. Muller, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long term survival of thoracoscopic metastasectomy vs metastasectomy by thoracotomy in patients with a solitary pulmonary lesion.

A. Hart, E. Rutgers, P. Baas, 2002, European Journal of Surgical Oncology.

Outcome of thoracoscopic pulmonary metastasectomy evaluated by confirmatory thoracotomy.

A. Hart, E. Rutgers, P. Baas, 2001, The Annals of thoracic surgery.

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†.

D. Planchard, P. Jänne, M. Ahn, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative Group.

G. Giaccone, M. van Glabbeke, T. Sutedja, 1997, European journal of cancer.